A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing

ISSN： 1175-5652

Source： Applied Health Economics and Health Policy, Vol.10, Iss.4, 2012-07, pp. : 217-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements: The Case of Continuous Intraduodenal Infusion of Levodopa/Carbidopa (Duodopa®) in Sweden

By Willis Michael

Applied Health Economics and Health Policy, Vol. 8, Iss. 6, 2010-11 ,pp. : 377-386

Adis International

Access to resources Recommend Favorite

Value-Based Insurance Design in Medicare

By Encinosa William E.

Applied Health Economics and Health Policy, Vol. 7, Iss. 3, 2009-09 ,pp. : 149-154

Adis International

Access to resources Recommend Favorite

The role of economic evaluation in the pricing and reimbursement of medicines

By Drummond M. Jonsson B. Rutten F.

Health Policy, Vol. 40, Iss. 3, 1997-06 ,pp. : 199-215

Elsevier

Access to resources Recommend Favorite

Does the UK National Health Service need a fourth hurdle for pharmaceutical reimbursement to encourage the more efficient prescribing of pharmaceuticals?

By Freemantle N.

Health Policy, Vol. 46, Iss. 3, 1999-03 ,pp. : 255-265

Elsevier

Access to resources Recommend Favorite

Financial incentives in health care. The impact of performance-based reimbursement

By Forsberg E. Axelsson R. Arnetz B.

Health Policy, Vol. 58, Iss. 3, 2001-12 ,pp. : 243-262

Elsevier

Access to resources Recommend Favorite